Posted by Chantel Martiromo, research contributed by PubMed
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. Lifestyle change alone is considered the first-line treatment
for the management of infertile anovulatory PCOS women who are
overweight or obese. According to the University of New South Wales,
posted in PubMed, first-line medical ovulation induction therapy
to improve fertility outcomes is clomiphene citrate, whilst
gonadotrophins, laparoscopic ovarian surgery or possibly metformin are
second line in clomiphene citrate-resistant PCOS women. There is
currently insufficient evidence to recommend aromatase inhibitors over
that of clomiphene citrate in infertile anovulatory PCOS women in
general or specifically in therapy naive or clomiphene citrate-resistant PCOS women. IVF/ICSI treatment is recommended either as a third-line treatment or in the presence of other infertility factors.
For the health Benefits and Side effects of Tofu, please visit http://medicaladvisorjournals.blogspot.ca/2011/12/world-most-healthy-foods-beans-legumes_03.html
Chinese Secrets to Fatty Liver and Obesity Reversal
A
Back to hormones http://medicaladvisorjournals.blogspot.ca/p/hormones.html
No comments:
Post a Comment